07/29/2025
3:16 PM | Kiniksa Pharmaceuticals International (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/29/2025
6:30 AM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2025
6:44 PM | BlackRock, Inc. (Filed by)
Kiniksa Pharmaceuticals International (Subject)
| Form SCHEDULE 13G/A | |
07/16/2025
3:30 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/14/2025
4:04 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2025
3:39 PM | Kiniksa Pharmaceuticals International (Issuer)
Levy Richard S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
3:39 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
4:23 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2025
4:32 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:35 PM | Kiniksa Pharmaceuticals International (Issuer)
Quart Barry D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
3:39 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for KNSA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Kiniksa Pharmaceuticals International and its competitors with MarketBeat's FREE daily newsletter. |
06/10/2025
4:46 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2025
3:50 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:53 PM | Kiniksa Pharmaceuticals International (Issuer)
Quart Barry D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:55 PM | Kiniksa Pharmaceuticals International (Issuer)
Popovits Kimberly J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:59 PM | Kiniksa Pharmaceuticals International (Issuer)
McCain Tracey L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
4:02 PM | Kiniksa Pharmaceuticals International (Issuer)
Malley Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
6:10 AM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2025
3:30 PM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2025
4:25 PM | Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2025
4:23 PM | Kiniksa Pharmaceuticals International (Filer)
| Form DEFA14A | |
05/22/2025
3:38 PM | Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
3:37 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:16 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2025
3:39 PM | Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:32 PM | Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2025
4:13 PM | Kiniksa Pharmaceuticals International (Subject)
Patel Sanj K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/05/2025
3:47 PM | Kiniksa Pharmaceuticals International (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:49 PM | Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:50 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:52 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:53 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:54 PM | Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
5:26 PM | Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
5:24 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
4:10 PM | Kiniksa Pharmaceuticals International (Subject)
Moat Ross (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2025
4:11 PM | Kiniksa Pharmaceuticals International (Subject)
Ragosa Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2025
3:15 PM | Kiniksa Pharmaceuticals International (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2025
6:40 AM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2025
6:47 PM | BlackRock, Inc. (Filed by)
Kiniksa Pharmaceuticals International (Subject)
| Form SCHEDULE 13G/A | |
04/23/2025
3:31 PM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
This Crypto Is Set to Explode in January (Ad) Billions Flowing Into Crypto (Here’s Where It’s Going!)
Institutional money is flooding into crypto...
Discover which coins they’re buying at the Crypto Hedge Fund Summit, before prices catch up. Claim your free seat now. |
04/23/2025
3:44 PM | Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:30 PM | Kiniksa Pharmaceuticals International (Filer)
| Form DEFA14A | |
04/16/2025
3:38 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2025
3:39 PM | Kiniksa Pharmaceuticals International (Filer)
| Form PRE 14A | |
04/09/2025
3:41 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
3:42 PM | Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
3:43 PM | Kiniksa Pharmaceuticals International (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
3:44 PM | Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
3:45 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
3:45 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2025
5:57 PM | Kiniksa Pharmaceuticals International (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13G | |
04/03/2025
4:06 PM | Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:52 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2025
3:35 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:48 PM | Kiniksa Pharmaceuticals International (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:49 PM | Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:50 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:51 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:52 PM | Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:53 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
4:29 PM | Kiniksa Pharmaceuticals International (Subject)
Ragosa Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2025
3:37 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
3:38 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
3:47 PM | Kiniksa Pharmaceuticals International (Subject)
Megna Michael R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2025
3:37 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
4:13 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/25/2025
3:31 PM | Kiniksa Pharmaceuticals International (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/25/2025
3:15 PM | Kiniksa Pharmaceuticals International (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/25/2025
6:31 AM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
2:45 PM | Fairmount Funds Management LLC (Filed by)
Kiniksa Pharmaceuticals International (Subject)
| Form SCHEDULE 13G/A | |
02/10/2025
4:37 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025
3:42 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:27 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
6:34 AM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
3:45 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
4:17 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
3:34 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
6:14 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:25 PM | Kiniksa Pharmaceuticals International (Subject)
Ragosa Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024
4:13 PM | Kiniksa Pharmaceuticals International (Subject)
Megna Michael R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
4:50 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
3:32 PM | HHLR ADVISORS, LTD. (Filed by)
Kiniksa Pharmaceuticals International (Subject)
| Form SC 13G/A | |
11/13/2024
3:30 PM | Kiniksa Pharmaceuticals International (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G/A | |
11/06/2024
3:11 PM | Kiniksa Pharmaceuticals International (Subject)
Patel Sanj K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024
3:14 PM | Kiniksa Pharmaceuticals International (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/29/2024
6:31 AM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Kiniksa Pharmaceuticals International (Subject)
| Form SC 13G | |
10/17/2024
3:35 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
3:57 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024
4:29 PM | BAKER BROS. ADVISORS LP (Filed by)
Kiniksa Pharmaceuticals International (Subject)
| Form SC 13D/A | |
$100 Trillion “AI Metal” Found in American Ghost Town (Ad) Jeff Brown recently traveled to a ghost town in the middle of an American desert…
To investigate what could be the biggest technology story of this decade.
In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom…
And only one company here in the U.S. can mine this obscure metal. Click here to get the details on this virtual monopoly. |
10/08/2024
4:08 PM | Boyd Meta Cantey (Reporting)
Kiniksa Pharmaceuticals International (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/08/2024
3:40 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:14 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Kiniksa Pharmaceuticals International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
3:39 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
4:02 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
7:57 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:51 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:52 PM | Kiniksa Pharmaceuticals International (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:53 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
